Dramatic response of a BRAF pV600E-mutated, primary CNS histiocytic sarcoma, to vemurafenib.

Idbaih A, Mokhtari K, Emile JF, Galanaud D, Belaid H, de Bernard S, Benameur N, Barlog VC, Psimaras D, Donadieu J, Carpentier C, Martin-Duverneuil N, Haroche J, Feuvret L, Zahr N, Delattre JY, Hoang-Xuan K. Neurology. 2014 Oct; 83(16):1478-80. (link)